Does Hormone Replacement Therapy Cause Ovarian Cysts?
No, hormone replacement therapy (HRT) does not cause ovarian cysts in postmenopausal women and may actually reduce their occurrence in early postmenopause.
Key Evidence on HRT and Ovarian Cysts
The relationship between HRT and ovarian cysts is reassuring:
HRT does not increase ovarian cyst prevalence in postmenopausal women overall, with similar rates observed in HRT users (10.5%) versus non-users (12.5%) 1.
In early postmenopausal women (ages 40-55), HRT is actually protective, significantly reducing ovarian cyst prevalence from 28.6% in non-users to 10.4% in HRT users 1.
Functional ovarian cysts in postmenopausal women are rare and only occur in recently menopausal women taking HRT or those not yet fully menopausal 2.
HRT may increase ovarian volume but does not increase functional ovarian cyst formation rates 3.
Important Distinction: Ovarian Cysts vs. Ovarian Cancer
It is critical to distinguish between benign ovarian cysts and ovarian cancer risk with HRT:
Ovarian Cancer Risk (Not Cysts)
Long-term HRT use (≥10 years) may increase ovarian cancer risk (RR 1.8-2.2) based on cohort studies, though evidence remains inconsistent 4.
Recent meta-analysis data suggest a small increase of 0.52 cases per 1,000 women starting HRT at age 50 and continuing for 5 years, with no difference between estrogen-only and combined estrogen-progestin therapy 5.
The Women's Health Initiative (WHI) found conflicting signals: in women aged 50-59, combined estrogen-progestin therapy showed a non-significant protective trend (HR 0.30) with only 2 versus 6 cases 5.
Evidence quality is insufficient to make definitive conclusions about ovarian cancer risk, as adequately powered randomized controlled trials are lacking 5.
Clinical Implications
For symptomatic postmenopausal women considering HRT:
The concern should focus on ovarian cancer risk with prolonged use (>10 years), not ovarian cyst formation 4, 5.
Functional ovarian cysts are not a contraindication to HRT and may actually be less common with HRT use in early postmenopause 1.
If an ovarian cyst develops during HRT, it should be evaluated with transvaginal ultrasound as the first-line imaging, with MRI for indeterminate masses 6.
Unilocular anechoic cysts <10 cm can be managed expectantly in asymptomatic women without cancer history, as hormone therapy is ineffective for treating functional cysts 6.
Common Pitfalls to Avoid
Do not confuse benign functional cysts with ovarian cancer risk—these are separate entities with different implications 4, 5, 1.
Do not withhold HRT solely due to concerns about ovarian cyst formation—the evidence shows no increased risk and possible benefit 1.
Do not attempt to treat functional ovarian cysts with HRT or oral contraceptives in postmenopausal women—this is ineffective 3, 6.